ArticleAmerican journal of ophthalmology case reports2025
Unusual presentation of fungal keratitis and endogenous endophthalmitis in Sézary syndrome: a case report.
Article in American journal of ophthalmology case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: This report describes an atypical presentation of Candida keratitis and subsequent endogenous bacterial endophthalmitis in a patient with Sézary Syndrome undergoing immunotherapy and subsequently chemotherapy. Observations: A male patient in his late sixties, a rigid gas permeable (RGP) contact lens wearer diagnosed with Sézary Syndrome and undergoing immunotherapy, presented with blurred vision and pain in the right eye. Examination showed a pseudodendritic infiltrate, severe anterior chamber inflammation with hypopyon and B-scan ultrasonography was unremarkable. Herpetic keratouveitis was suspected, and treatment was started with oral acyclovir, topical levofloxacin, and topical dexamethasone, with no improvement after 48 hours. Cultures identified Conclusion: This case highlights the complex relationship between systemic immunosuppression, ocular susceptibility and opportunistic endogenous infections, contributing to a challenging clinical course, diagnosis and treatment of patients with Sézary Syndrome. Clinicians should be aware of this risk of atypical and aggressive infectious presentations and carefully monitor these patients after chemotherapy cycles to detect potential complications early.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.